Freeman Mason

Track

Insider profile

Performance

Overall performance
3.3
Performance over holding periods
3.3
30 days 90 days 120 days
Average return 49% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Freeman Mason's trades of CinCor Pharma Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
308.69
Quantity 94,830 -14.2%
Value US$916,245
Transaction date
Purchase
Price
167.47
Quantity 4,002 +10.1%
Value US$4,476,583
Transaction date
Purchase
Price
494.90
Quantity 34,396 +27.8%
Value US$4,609,577
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-02-27 2022-06-10
S Sale
94,830 -14.2%
308.69
US$916,245 		94,830 -14.2% 308.69 US$916,245
2022-01-13 2022-01-11
B Purchase
4,002 +10.1%
167.47
US$4,476,583 		4,002 +10.1% 167.47 US$4,476,583
2022-01-13 2022-01-11
B Purchase
34,396 +27.8%
494.90
US$4,609,577 		34,396 +27.8% 494.90 US$4,609,577